-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Fate Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Fate Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$38.4M, a 27.2% increase year-over-year.
- Fate Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$176M, a 16.9% increase year-over-year.
- Fate Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$161M, a 42.9% increase from 2022.
- Fate Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$282M, a 32.8% decline from 2021.
- Fate Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$212M, a 22.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)